Organogenesis Holdings (ORGO) Change in Account Payables (2018 - 2026)

Organogenesis Holdings' Change in Account Payables history runs 9 years deep, the most recent figure standing at -$2.0 million for Q1 2026.

• In Q1 2026, Change in Account Payables rose 19.75% year-over-year to -$2.0 million; the TTM figure through Mar 2026 stood at -$35000.0 (up 92.66% YoY), while the FY2025 annual figure was -$528000.0, up 77.74% from the prior year.
• Change in Account Payables was -$2.0 million for Q1 2026 at Organogenesis Holdings, down from -$1.2 million in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $4.1 million in Q2 2025 to a low of -$4.4 million in Q1 2024.
• Historically, Change in Account Payables has averaged -$103000.0 across 5 years, with a median of -$1.2 million in 2025.
• The sharpest annual moves came in 2022 and 2024: Change in Account Payables jumped 442.54% in 2022, then plunged 2975.4% in 2024.
• A 5-year view of Change in Account Payables shows it stood at -$2.0 million in 2022, then soared by 277.56% to $3.6 million in 2023, then increased by 2.73% to $3.6 million in 2024, then tumbled by 132.08% to -$1.2 million in 2025, then tumbled by 71.05% to -$2.0 million in 2026.
• The last three Change in Account Payables figures came in at -$2.0 million (Q1 2026), -$1.2 million (Q4 2025), and -$994000.0 (Q3 2025), per Business Quant data.